Dr. Mintun is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3711 Market St
Philadelphia, PA 19104Phone+1 215-798-6022
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Nuclear Medicine, 1984 - 1985- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1981 - 1982
- Washington University in St. Louis School of MedicineClass of 1981
Massachusetts Institute of TechnologyBS, Chemical Engineering, 1973 - 1977
Certifications & Licensure
- American Board of Nuclear Medicine Nuclear Medicine
Publications & Presentations
PubMed
- 263 citationsRelationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.Michael J. Pontecorvo, Michael D. Devous, Michael Navitsky, Ming Lu, Stephen Salloway
Brain. 2017-03-01 - 509 citationsAmyloid deposition, hypometabolism, and longitudinal cognitive decline.Susan M. Landau, Mark A. Mintun, Abhinay Joshi, Robert A. Koeppe, Ronald C. Petersen
Annals of Neurology. 2012-10-01 - 186 citationsAntidepressant treatment normalizes hypoactivity in dorsolateral prefrontal cortex during emotional interference processing in major depressionChristina L. Fales, M Deanna, Melissa M. Rundle, Mark A. Mintun, Jose Mathews
Journal of Affective Disorders. 2009-01-01
Press Mentions
Eli Lilly's Alzheimer's Drug Earns FDA Advisory Panel Backing. Here's What to KnowJune 11th, 2024- FDA Commissioner Is “Excited” About New Alzheimer’s Treatment ResultsMay 5th, 2023
- New Alzheimer's Drug Slows Disease by a ThirdMay 3rd, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
